Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 5, 2015, Pages 2607-2617

  Takashita, Emi ^a   Kiso, Maki ^b   Fujisaki, Seiichiro ^a   Yokoyama, Masaru ^a   Nakamura, Kazuya ^a   Shirakura, Masayuki ^a   Sato, Hironori ^a   Odagiri, Takato ^a   Kawaoka, Yoshihiro ^b,c,d   Tashiro, Masato ^a   Komagome, Rika ^e   Miyoshi, Masahiro ^e   Nagano, Hideki ^e   Ohnishi, Asami ^f   Tsutsui, Rika ^g   Takahashi, Masaki ^h   Suzuki, Yuko ⁱ   Nakata, Ayumi ^j   Aoki, Chihiro Shibata Yoko ^k,l   Kitakawa, Kaduhiro ^m   Hirokawa, Chika ⁿ   Yamamoto, Kazunari ^o   Doi, Ikuko ^p   Mizukoshi, Fuminori ^q   Nagashima, Chikako ^r   Tsukagoshi, Hiroyuki ^s   Suzuki, Noriko ^t   Uno, Yuka ^u   Ogura, Atsushi ^v   Mizumura, Ayano ^w   Harada, Sachiko ^x   Watanabe, Sumi ^y   Kawakami, Chiharu ^z   Shimizu, Hideaki ^aa   Yamaguchi, Junko ^ab   Mochizuki, Kyoko ^ac   Oonuma, Masayuki ^ad   Kobayashi, Hiroki ^ae   Okamura, Yuichiro ^af   Yamada, Toshihiro ^ag   Shibahara, Nona ^ah   Jimbo, Tatsuya ^ai   Obuchi, Masatsugu ^aj   Kodama, Hiroe ^ak   Noda, Nozomi ^al   Kuzuguchi, Tsuyoshi ^am   Tanaka, Yasunori ^an   Yasui, Yoshihiro ^ao   Yano, Takuya ^ap   Kodama, Hiromi ^aq   Watanabe, Masayoshi ^ar   Hiroi, Satoshi ^as   Kubo, Hideyuki ^at   Uchino, Kiyoko ^au   Oshibe, Tomohiro ^av   Mori, Ai ^aw   Yoneda, Masaki ^ax   Terasoma, Fumio ^ay   Ekawa, Hidenobu ^az   Kato, Nobuyuki ^ba   Takimoto, Hirokazu ^bb   Hamano, Masako ^bc   Takao, Shinichi ^bd   Yamamoto, Miwako ^be   Toda, Shoichi ^bf   Katayama, Miyuki ^bg   Terajima, Yukari ^bh   Kan, Miki ^bi   Taniwaki, Tae ^bj   Yoshitomi, Hideaki ^bk   Kajiyama, Keiko ^bl   Sakata, Wakako ^bm   Ando, Katsuyuki ^bn   Kitagawa, Yumika ^bo   Toda, Junko ^bp   Nishizawa, Kaori ^bq   Kato, Miki ^br   Miura, Miho ^bs   Mutsuyo, Gokuden ^bt   Kyan, Hisako ^bu   more..

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e HOKKAIDO INSTITUTE OF PUBLIC HEALTH   (Japan)

^f Sapporo City Institute of Public Health   (Japan)

^g Aomori Prefectural Institute of Public Health and Environment   (Japan)

^h Research Institute for Environmental Sciences and Public Health of Iwate Prefecture   (Japan)

ⁱ Miyagi Prefectural Institute of Public Health and Environment   (Japan)

^j Sendai City Institute of Public Health   (Japan)

^k Akita Research Center for Public Health and Environment   (Japan)

^l YAMAGATA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^m Department of Bacteriology   (Japan)

ⁿ Niigata Prefectural Institute of Public Health And Environmental Sciences   (Japan)

^o Niigata City Institute of Public Health and Environment   (Japan)

^p Ibaraki Prefectural Institute of Public Health   (Japan)

^q Tochigi Prefectural Institute of Public Health and Environmental Sciences   (Japan)

^r Utsunomiya City Institute of Public Health and Environment Science   (Japan)

^s GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^t SAITAMA INSTITUTE OF PUBLIC HEALTH   (Japan)

^u National Institute of Health Sciences   (Japan)

^v CHIBA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^w Chiba City Institute of Health and Environment   (Japan)

^x TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^y KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^z Yokohama City Institute of Health   (Japan)

^aa Kawasaki City Institute of Public Health   (Japan)

^ab Yokosuka City Institute of Public Health   (Japan)

^ac Sagamihara City Laboratory of Public Health   (Japan)

^ad Yamanashi Institute for Public Health   (Japan)

^ae NAGANO ENVIRONMENTAL CONSERVATION RESEARCH INSTITUTE   (Japan)

^af Nagano City Health Center   (Japan)

^ag SHIZUOKA INSTITUTE OF ENVIRONMENT AND HYGIENE   (Japan)

^ah Shizuoka City Institute of Environmental Sciences and Public Health   (Japan)

^ai Hamamatsu City Health Environment Research Center   (Japan)

^aj TOYAMA INSTITUTE OF HEALTH   (Japan)

^ak Ishikawa Prefectural Institute of Public Health and Environmental Science   (Japan)

^al Fukui Prefectural Institute of Public Health and Environmental Science   (Japan)

^am Gifu Prefectural Research Institute for Health and Environmental Sciences   (Japan)

^an Gifu Municipal Institute of Public Health   (Japan)

^ao AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^ap Mie Prefectural Health and Environment Research Institute   (Japan)

^aq Shiga Pref Inst Pub Hlth E   (Japan)

^ar Kyoto City Institute of Health and Environmental Sciences   (Japan)

^as OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^at OSAKA CITY INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^au Sakai City Institute of Public Health   (Japan)

^av Infectious Disease Research Division Hyogo Prefectural Institute of Public Health and Consumer Sciences   (Japan)

^aw KOBE INSTITUTE OF HEALTH   (Japan)

^ax Nara Prefectural Institute of Health   (Japan)

^ay Wakayama Prefectural Research Center of Environment and Public Health   (Japan)

^az Wakayama City Inst of Public Health   (Japan)

^ba Tottori Prefectural Institute of Public Health and Environmental Science   (Japan)

^bb SHIMANE PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCE   (Japan)

^bc Okayama Prefectural Institute for Environmental Science and Public Health   (Japan)

^bd HIROSHIMA PREFECTURAL TECHNOLOGY RESEARCH INSTITUTE   (Japan)

^be Hiroshima City Institute of Public Health   (Japan)

^bf Yamaguchi Prefectural Institute of Public Health and Environment   (Japan)

^bg Pharmaceutical and Environmental Sciences Center   (Japan)

^bh Kagawa Pref Inst of Public Health   (Japan)

^bi Ehime Prefecture Institute of Public Health and Environmental Science   (Japan)

^bj Kochi Public Health and Sanitation Institute   (Japan)

^bk FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^bl Fukuoka City Institute for Hygiene and the Environment   (Japan)

^bm Kitakyushu City Institute of Environmental Sciences   (Japan)

^bn Saga Prefectural Institute of Public Health and Pharmaceutical Research   (Japan)

^bo Nagasaki Pref Inst Hlth E   (Japan)

^bp Kumamoto Prefectural Institute of Public Health and Environmental Science   (Japan)

^bq Kumamoto City Environmental Research Center   (Japan)

^br Oita Prefectural Institute of Health and Environment   (Japan)

^bs Miyazaki Prefectural Institute for Public Health and Environment   (Japan)

^bt Kagoshima Prefectural Institute for Environmental Research and Public Health   (Japan)

^bu OKINAWA PREFECTURAL INSTITUTE OF HEALTH AND ENVIRONMENT   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LANINAMIVIR; OSELTAMIVIR; PERAMIVIR; VIRUS SIALIDASE; ZANAMIVIR; ANTIVIRUS AGENT; CYCLOPENTANE DERIVATIVE; GUANIDINE DERIVATIVE; VIRAL PROTEIN;

2009 H1N1 INFLUENZA; ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; FEMALE; FERRET; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A (H1N1)PDM09; INFLUENZA VIRUS A H1N1; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REPRODUCTIVE FITNESS; SEASONAL INFLUENZA; STRAIN DIFFERENCE; UPPER RESPIRATORY TRACT; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; WILD TYPE; DRUG EFFECTS; GENETICS; INFLUENZA A VIRUS (H1N1);

ANTIVIRAL AGENTS; CYCLOPENTANES; DRUG RESISTANCE, VIRAL; GUANIDINES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; JAPAN; OSELTAMIVIR; VIRAL PROTEINS;

EID: 84931291764     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04836-14     Document Type: Article

References (25)

1. World Health Organization. 2010. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/resources/publications/swineflu/h1n1-use-antivirals-20090820/en/.
2. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M. 2006. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50:2395-2402. http://dx.doi.org/10.1128/AAC.01339-05.
3. Tashiro M, McKimm-Breschkin JL, Saito T, Klimov A, Macken C, Zambon M, Hayden FG, Neuraminidase Inhibitor Susceptibility Network. 2009. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. Antivir Ther 14:751-761. http://dx.doi.org/10.3851/IMP1194.
4. Ujike M, Shimabukuro K, Mochizuki K, Obuchi M, Kageyama T, Shirakura M, Kishida N, Yamashita K, Horikawa H, Kato Y, Fujita N, Tashiro M, Odagiri T, Working Group for Influenza Virus Surveillance in Japan. 2010. Oseltamivir-resistant influenza viruses A(H1N1) during 2007-2009 influenza seasons, Japan. Emerg Infect Dis 16:926-935. http://dx.doi.org/10.3201/eid1606.091623.
5. Ujike M, Ejima M, Anraku A, Shimabukuro K, Obuchi M, Kishida N, Hong X, Takashita E, Fujisaki S, Yamashita K, Horikawa H, Kato Y, Oguchi A, Fujita N, Tashiro M, Odagiri T, Influenza Virus Surveillance Group of Japan. 2011. Monitoring and characterization of oseltamivirresistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis 17:470-479. http://dx.doi.org/10.3201/eid1703.101188.
6. Takashita E, Fujisaki S, Kishida N, Xu H, Imai M, Tashiro M, Odagiri T, Influenza Virus Surveillance Group of Japan. 2013. Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan. Influenza Other Respir Viruses 7:1390-1399. http://dx.doi.org/10.1111/irv.12132.
7. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC. 2008. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 13:pii=8026. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8026.
8. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328:1272-1275. http://dx.doi.org/10.1126/science.1187816.
9. Rameix-Welti MA, Munier S, Le Gal S, Cuvelier F, Agou F, Enouf V, Naffakh N, van der Werf S. 2011. Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution. Antivir Ther 16:597-603. http://dx.doi.org/10.3851/IMP1804.
10. Abed Y, Pizzorno A, Bouhy X, Boivin G. 2011. Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses. PLoS Pathog 7:e1002431. http://dx.doi.org/10.1371/journal.ppat.1002431.
11. Bouvier NM, Rahmat S, Pica N. 2012. Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivirresistant neuraminidase. J Virol 86:7268-7279. http://dx.doi.org/10.1128/JVI.07242-12.
12. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG. 2012. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 206:148-157. http://dx.doi.org/10.1093/infdis/jis337.
13. Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, Guarnaccia T, Baas C, Xue L, Vitesnik S, Leang SK, McVernon J, Kelso A, Barr IG, McCaw JM, Bloom JD, Hurt AC. 2014. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathog 10:e1004065. http://dx.doi.org/10.1371/journal.ppat.1004065.
14. Abed Y, Pizzorno A, Bouhy X, Rhéaume C, Boivin G. 2014. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets. J Virol 88:1652-1658. http://dx.doi.org/10.1128/JVI.02681-13.
15. Takashita E, Ejima M, Itoh R, Miura M, Ohnishi A, Nishimura H, Odagiri T, Tashiro M. 2014. A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013. Euro Surveill 19:pii=20666. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20666.
16. Nakauchi M, Ujike M, Obuchi M, Takashita E, Takayama I, Ejima M, Oba K, Konomi N, Odagiri T, Tashiro M, Kageyama T, Influenza Virus Surveillance Group of Japan. 2011. Rapid discrimination of oseltamivirresistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay. J Med Virol 83:1121-1127. http://dx.doi.org/10.1002/jmv.22101.
17. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 30:2725-2729. http://dx.doi.org/10.1093/molbev/mst197.
18. Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS, Hurt AC. 2014. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013. Antiviral Res 110:31-41. http://dx.doi.org/10.1016/j.antiviral.2014.07.001.
19. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman- Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, et al. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021-1025. http://dx.doi.org/10.1038/nature08260.
20. Hatakeyama S, Sakai-Tagawa Y, Kiso M, Goto H, Kawakami C, Mitamura K, Sugaya N, Suzuki Y, Kawaoka Y. 2005. Enhanced expression of an α2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 43:4139-4146. http://dx.doi.org/10.1128/JCM.43.8.4139-4146.2005.
21. van der Vries E, Collins PJ, Vachieri SG, Xiong X, Liu J, Walker PA, Haire LF, Hay AJ, Schutten M, Osterhaus AD, Martin SR, Boucher CA, Skehel JJ, Gamblin SJ. 2012. H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog 8:e1002914. http://dx.doi.org/10.1371/journal.ppat.1002914.
22. Nomaguchi M, Yokoyama M, Kono K, Nakayama EE, Shioda T, Doi N, Fujiwara S, Saito A, Akari H, Miyakawa K, Ryo A, Ode H, Iwatani Y, Miura T, Igarashi T, Sato H, Adachi A. 2013. Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors. J Virol 87:11447-11461. http://dx.doi.org/10.1128/JVI.01549-13.
23. Okomo-Adhiambo M, Fry AM, Su S, Nguyen HT, Elal AA, Negron E, Hand J, Garten RJ, Barnes J, Xiyan X, Villanueva JM, Gubareva LV, 2013-14 U.S. Influenza Antiviral Working Group. 2015. Oseltamivirresistant influenza A(H1N1)pdm09 viruses, United States, 2013-14. Emerg Infect Dis 21:136-141. http://dx.doi.org/10.3201/eid2101/141006.
24. Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC, Tashiro M. 2015. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. Antiviral Res 117:27-38. http://dx.doi.org/10.1016/j.antiviral.2015.02.003.
25. Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y. 2012. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J Virol 86:121-127. http://dx.doi.org/10.1128/JVI.06085-11.